Cargando…
Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
People with multiple sclerosis (MS) are at risk for infections that can result in amplification of baseline symptoms and possibly trigger clinical relapses. Vaccination can prevent infection through the activation of humoral and cellular immune responses. This is particularly pertinent in the era of...
Autores principales: | Coyle, Patricia K., Gocke, Anne, Vignos, Megan, Newsome, Scott D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169434/ https://www.ncbi.nlm.nih.gov/pubmed/34075554 http://dx.doi.org/10.1007/s12325-021-01761-3 |
Ejemplares similares
-
Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
por: Coyle, Patricia K., et al.
Publicado: (2021) -
Era of COVID-19 in Multiple Sclerosis Care
por: Krett, Jonathan D., et al.
Publicado: (2023) -
Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey
por: Tumani, Hayrettin, et al.
Publicado: (2023) -
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
por: Monschein, Tobias, et al.
Publicado: (2021) -
Vaccine response in people with multiple sclerosis treated with fumarates
por: Tremblay, Matthew A., et al.
Publicado: (2023)